DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/5b85a0/medicated_skin_car) has announced the addition of the "Medicated Skin Care in South Africa" report to their offering.
The Medicated Skin Care Products in South Africa report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Medicated skin care increased by 6% in current value terms in 2009 to reach R824 million. Growth in that year was marginally more successful than the review period average. Growth was equally split between antifungals and other medicated skin care. This sector was driven by HIV/AIDS sufferers making use of the products to combat skin conditions that culminated in the beginning stages of the disease, increasing stress levels as well as the use of antibiotics.
Product coverage: Acne Treatments, Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Child-Specific Medicated Skin Care, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Consumer Health industry;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the markets major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Key Topics Covered:
- Executive Summary
- Steady Growth in Challenging Retail Environment
- Self-medication Plays Major Role in Volume Sales
- OTC Sales Dominated by A Small Number of Players
- Grocery Channels Increase Footprint
- Health Concerns at the Forefront of Consumers' Minds
- Key Trends and Developments
- In-store Pharmacies Expand Footprint
- Recession Forces Companies To Increase Their Advertising Campaigns
- Increased Self-medication Expands Untrustworthy Trade Footprint
- Hiv/aids Symptoms and Side-effects Elevate OTC Sales
- Growing Appeal for Natural/herbal Variants
- Market Indicators
List of Tables
- Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
- Table 2 Life Expectancy at Birth 2004-2009
- Table 3 Sales of Consumer Health by Sector: Value 2004-2009
- Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
- Table 5 Consumer Health Company Shares by Value 2005-2009
- Table 6 Consumer Health Brand Shares by Value 2006-2009
- Table 7 Penetration of Private Label by Sector 2004-2009
- Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
- Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
- Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
- Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
- Table 12 Sales of Medicated Skin Care by Subsector: Value 2004-2009
- Table 13 Sales of Medicated Skin Care by Subsector: % Value Growth 2004-2009
- Table 14 Acne Treatments by Format: % Value Breakdown 2004-2009
- Table 15 Medicated Skin Care Company Shares by Value 2005-2009
- Table 16 Medicated Skin Care Brand Shares by Value 2006-2009
- Table 17 Acne Treatments Brand Shares by Value 2006-2009
- Table 18 Hair Loss Treatments Brand Shares by Value 2006-2009
- Table 19 Forecast Sales of Medicated Skin Care by Subsector: Value 2009-2014
- Table 20 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2009-2014
Companies Mentioned:
- Adcock Ingram Ltd
- Aspen Pharmacare (pty) Ltd
- Bioscience Brands Ltd
- Cipla-medpro (pty) Ltd
- Dischem (pty) Ltd
- Novartis South Africa (pty) Ltd
For more information visit http://www.researchandmarkets.com/research/5b85a0/medicated_skin_car
Source: Euromonitor International

